(Q46560077)

23 December 2017

title

Gene expression analysis identifies two groups of ovarian high-grade serous carcinomas with different prognosis (English)

1 reference

23 December 2017

author name string

Inigo Espinosa

1

1 reference

23 December 2017

Lluis Catasus

2

1 reference

23 December 2017

Belén Canet

3

1 reference

23 December 2017

Emanuela D'Angelo

4

1 reference

23 December 2017

Josefina Muñoz

5

1 reference

23 December 2017

Jaime Prat

6

1 reference

23 December 2017

publication date

11 February 2011

1 reference

23 December 2017

published in

Modern Pathology

1 reference

23 December 2017

volume

24

1 reference

23 December 2017

issue

6

1 reference

23 December 2017

page(s)

846-854

1 reference

23 December 2017

https://scigraph.springernature.com/pub.10.1038/modpathol.2011.12

exact match

0 references

cites work

A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

Expression profiling of 22 genes involved in the PI3K-AKT pathway identifies two subgroups of high-grade endometrial carcinomas with different molecular alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

Concomitant PI3K-AKT and p53 alterations in endometrial carcinomas are associated with poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

Frequent mutation of the PIK3CA gene in ovarian and breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

Activation of Akt predicts poor outcome in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

Oncogenic PI3K deregulates transcription and translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

Emerging roles of caspase-3 in apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

The anti-apoptotic activity of XIAP is retained upon mutation of both the caspase 3- and caspase 9-interacting sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

DNA copy numbers profiles in affinity-purified ovarian clear cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

Tangeretin sensitizes cisplatin-resistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase/Akt signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

Cleaved caspase-3 and nuclear factor-kappaB p65 are prognostic factors in metastatic serous ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

PTEN expression in clear cell adenocarcinoma of the ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

7 January 2021

Ovarian clear cell carcinomas: RHO GTPases may contribute to explain their singular biologic behavior.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

7 January 2021

XIAP as target for therapeutic apoptosis in prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

7 January 2021

Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

7 January 2021

Experimental approaches to the study of cancer-stroma interactions: recent findings suggest a pivotal role for stroma in carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

7 January 2021

Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.12

7 January 2021

10.1038/MODPATHOL.2011.12

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017